Question

In: Finance

2. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...

2. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product that is now under development is approved by the Food and Drug Administration. If the FDA rejects the competitive product upon the completion of its development, NPC’s product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a 75% chance that the competitive product will be rejected, in which case NPC’s expected cash flows will be $550 at the end of each of the next seven years (t = 1 to 7). There is a 25% chance that the competitor’s product will be approved, in which case the expected cash flows will be only $20 at the end of each of the next seven years (t = 1 to 7). NPC will know only sometime later whether the competitor’s product is going to be approved.

NPC will proceed with the investment today to take advantage of the untapped market potential and at the end of the project’s life, after finding out about the FDA’s decision about the demand for competitor’s product, they will decide whether or not to renew the patent and rerun the project. The project rerun’s upfront cost (at t = 7) will remain at $1,500, and the subsequent cash flows will remain unchanged and will be received for seven additional years (t = 8 ... 14). They will only rerun the project if the rerun of the project adds value.

Assuming that all cash flows are discounted at 10%, what is the NPV of the project with and without the growth option?

Solutions

Expert Solution

COMPUTATION OF NPV OF PROJECT

With Growth (for 14 years)

Years Cash Flow if Competitor's product accepted Probability of acception Cash Flow if Competitor's product rejected Probability of rejection Expected Cash Flows Present Value Factor Present Value
a b c d e f=(b*c)+(d*e) g h=f*g
1 $550.00 0.25 $20.00 0.75 $152.50 0.909 $138.64
2 $550.00 0.25 $20.00 0.75 $152.50 0.826 $126.03
3 $550.00 0.25 $20.00 0.75 $152.50 0.751 $114.58
4 $550.00 0.25 $20.00 0.75 $152.50 0.683 $104.16
5 $550.00 0.25 $20.00 0.75 $152.50 0.621 $94.69
6 $550.00 0.25 $20.00 0.75 $152.50 0.564 $86.08
7 -$950.00 0.25 $20.00 0.75 -$222.50 0.513 -$114.18
8 $550.00 NA NA NA $550.00 0.467 $256.58
9 $550.00 NA NA NA $550.00 0.424 $233.25
10 $550.00 NA NA NA $550.00 0.386 $212.05
11 $550.00 NA NA NA $550.00 0.350 $192.77
12 $550.00 NA NA NA $550.00 0.319 $175.25
13 $550.00 NA NA NA $550.00 0.290 $159.32
14 $550.00 NA NA NA $550.00 0.263 $144.83
PV of Inflow (I) $1,924.05
Less: Outflow at year 1 (O) $1,500.00
NPV (I - O) $424.05

Thus, In case of Growth, NPV of the project will be $ 424.05

NOTE:- Growth (i.e investment in Year 7 will be undertaken only if competitors product is rejected in which case the Net cash inflows will be $550 and probability of acceptance and rejection will not be applicable.

Without Growth (for 7 years)

Years Cash Flow if Competitor's product accepted Probability of acception Cash Flow if Competitor's product rejected Probability of rejection Expected Cash Flows Present Value Factor Present Value
a b c d e f=(b*c)+(d*e) g h=f*g
1 $550.00 0.25 $20.00 0.75 $152.50 0.909 $138.64
2 $550.00 0.25 $20.00 0.75 $152.50 0.826 $126.03
3 $550.00 0.25 $20.00 0.75 $152.50 0.751 $114.58
4 $550.00 0.25 $20.00 0.75 $152.50 0.683 $104.16
5 $550.00 0.25 $20.00 0.75 $152.50 0.621 $94.69
6 $550.00 0.25 $20.00 0.75 $152.50 0.564 $86.08
7 $550.00 0.25 $20.00 0.75 $152.50 0.513 $78.26
PV of Inflow (I) $742.43
Less: Outflow at year 1 (O) $1,500.00
NPV (I - O) -$757.57

Therefore, in case of no growth, NPV will be - $757.57

Please upvote the answer if it was of help to you.
In case of any doubt just comment below, I would love to help.


Related Solutions

1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...
1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC’s product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a 75%...
A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical...
A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product that is now under development is approved by the Food and Drug Administration. If the FDA rejects the competitive product upon the completion of its development, NPC’s product will have high sales and cash flows, but if the competitive product is...
3. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...
3. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide PharmaceuticalCorporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows arecritically dependent on whether a competitor’s product that is now under development is approved by the Food and Drug Administration. If the FDA rejects the competitive product upon the completion of its development, NPC’s product will have high sales and cash flows, but if the competitive product is approved,...
1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...
1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC’s product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a 75%...
A project with an up-front cost at t = 0 of $1500 is being considered by...
A project with an up-front cost at t = 0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project's subsequent cash flows are critically dependent on whether a competitor's product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC's product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a...
A project with an up-front cost at t = 0 of $1500 is being considered by...
A project with an up-front cost at t = 0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project's subsequent cash flows are critically dependent on whether a competitor's product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC's product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a...
Firm C is considering a project with an up-front cost at t = 0 of $1500....
Firm C is considering a project with an up-front cost at t = 0 of $1500. (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product is approved by the Food and Drug Administration (FDA). If the FDA rejects the competitive product, C’s product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact company C. There is a 75% chance...
A project has an initial, up-front cost of $10,000, at t = 0. The project is...
A project has an initial, up-front cost of $10,000, at t = 0. The project is expected to produce cash flows of $2,200 for the next three years. The project’s cash flows depend critically upon customer acceptance of the product. There is a 60% probability that the product will be wildly successful and produce CFs of $5,000, and a 40% chance it will produce annual CFs of -$2,000. At a 10% WACC, what is this project’s NPV with abandonment option?...
The Z-90 project being considered by Steppingstone Inc. (SI) has an up-front cost of $250,000. The...
The Z-90 project being considered by Steppingstone Inc. (SI) has an up-front cost of $250,000. The project's subsequent cash flows are critically dependent on whether another one of its products, Z-45, becomes an industry standard. There is a 60% chance that the Z-45 will become the industry standard, in whihc case the Z-90's expected cash flows will be $110,000 at the end of each of the next 5 years. There is a 40% chance that the Z-45 will not become...
A company is considering a project that has an up-front cost paid today at t =...
A company is considering a project that has an up-front cost paid today at t = 0. The project will generate positive cash flows of $50,175 a year at the end of each for the next 5 years. The project’s NPV is $87,983 and the company’s return on the project is 8.3 percent. What is the project’s payback?
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT